For the second year in a row, Gartner has included Tact.ai, the customer engagement company for life sciences, in its Hype Cycle for Life Sciences Commercial Operations.
The latest edition of the Hype Cycle report categorizes voice-driven sales apps as a high-impact technology. “Prioritize this functionality based upon the time-saving efficiencies offered for both voice-driven data entry and data retrieval,” writes report author Animesh Gandhi. “This is also very relevant for companies struggling to improve SFA adoption, because these systems work best for reducing manual data entry or manual data retrieval, helping to replace inefficient user interface patterns such as manual pick lists and manual data entry forms.”
The Hype Cycle report aims to help technology leaders track key emerging technologies that can help them better engage customers, grow revenues, and reduce costs.
The report notes the broader trend toward accelerating digital adoption for life science organizations (LSOs). “The COVID-19 pandemic drove new imperatives to realize the power of data and technologies such as digital and virtual engagement that had been sitting at the peripheries for years. In response to the pandemic, LSOs immediately accelerated the application of advanced data analytics technologies to personalize customer engagement, deploy new digital channels, advance patient-engagement strategies and pursue new health value creation opportunities.”
The Life Sciences industry is transforming at a rapid pace. With newer Go-to-Market strategies and shift towards omnichannel models, the goal is to re-define HCP engagement and boost the productivity of customer-facing teams. The Tact customer engagement platform combines AI, data gathering, and UX together to make reps and MSLs more effective. In an interview with Tact.ai, Stan Tsvirko from Novartis explained how Tact supports seamless collaboration across platforms, helping to prioritize communicating with HCPs according to their preferences.
Gartner also cited Tact.ai as a sample vendor for both Voice-Driven Sales Apps and MobileSales Productivity Apps in its recent "Hype Cycle for Resales Technology,2021.”
The Customer Engagement Company for Life Sciences
Tact.ai is on a mission to help life science organizations nurture meaningful customer engagement through our human-friendly software. Our AI-powered engagement platform empowers field teams to work with their customers in new ways to drive better outcomes. Tact.ai is headquartered in Silicon Valley and is backed by some of the world’s leading firms in venture capital, technology, and healthcare and life sciences, including Microsoft’s venture fund M12, Salesforce Ventures, Novartis, Lilly, and McKesson Ventures. Visit us at: https://www.tact.ai/
Gartner "Hype Cycle for Life Science Commercial Operations, 2021," Amines Gandhi, 14 July 2021
Gartner "Hype Cycle for CRM Sales Technology, 2021," Adnan Izadi, Melissa Hilbert, 26 July 2021
Face-to-face detailing by field teams has been the tried and tested method of promotion in the pharmaceutical industry for decades, a look at how we are returning to field!
This week on May 17th and 18th, our team at Tact.ai attended the Next Pharma Summit 2022.Our team was delighted to be a part of the discussions about the future of customer engage
On Saturday, April 2nd, we at Tact.ai attended the 71st Annual American College of Cardiology Scientific Sessions (ACC.22) in Washington, D.C.
Tact’s immersive and connected customer experience helps customer-facing teams to create a true, no-friction, omnichannel on-demand experience for HCPs.
Tact customer engagement platform drives the last mile of the Next Best Action engine or other Customer Insights Programs enabling field teams with greater actionability